L-Type Cav 1.2 Calcium Channel-α-1C Regulates Response to Rituximab in Diffuse Large B-Cell Lymphoma-Reference-Cited by-同舟云学术

L-Type Cav 1.2 Calcium Channel-α-1C Regulates Response to Rituximab in Diffuse Large B-Cell Lymphoma

Published:2019-03-01 Issue:13 Volume:25 Page:4168-4178
ISSN:1078-0432
Container-title:Clinical Cancer Research
language:en
Short-container-title:Clin Cancer Res

Author:

Zhang Jiu-Yang,Zhang Pei-Pei,Zhou Wen-Ping,Yu Jia-Yu,Yao Zhi-Hua,Chu Jun-Feng,Yao Shu-Na,Wang Cheng,Lone Waseem,Xia Qing-Xin,Ma Jie,Yang Shu-Jun,Liu Kang-Dong,Dong Zi-Gang,Guo Yong-Jun,Smith Lynette M.^ORCID,McKeithan Timothy W.,Chan Wing C.,Iqbal Javeed,Liu Yan-Yan

Funder

National Natural Science Foundation of ChinaNational Natural Science Foundation of China (NSFC)

HHS | NIH | National Cancer InstituteHHS | NIH | National Cancer Institute (NCI)

Leukemia and Lymphoma SocietyLeukemia and Lymphoma Society (LLS)

Lymphoma Research FoundationLymphoma Research Foundation (LRF)

Publisher

American Association for Cancer Research (AACR)

Subject

Cancer Research,Oncology

Cited by 19 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Environmental endocrine disrupting chemical 4-tert-butylphenol induced calcium overload and subsequent autophagy impairment via miRNA-363/CACNA1D Axis in epithelioma papulosum cyprini cells;Comparative Biochemistry and Physiology Part C: Toxicology & Pharmacology;2024-09

2. Unveiling the PDK4-centered rituximab-resistant mechanism in DLBCL: the potential of the “Smart” exosome nanoparticle therapy;Molecular Cancer;2024-07-15

3. Dysregulation of calcium homeostasis in cancer and its role in chemoresistance;Cancer Drug Resistance;2024-03-15

4. CACNA1C mutation as a prognosis predictor of immune checkpoint inhibitor in skin cutaneous melanoma;Immunotherapy;2023-10

5. Hypoxia-regulated secretion of IL-12 enhances antitumor activity and safety of CD19 CAR-T cells in the treatment of DLBCL;Molecular Therapy - Oncolytics;2023-09